Alcami Corporation, a contract development and manufacturing organisation (CDMO), announced on Thursday that it has named Jamie Iudica as its new chief manufacturing officer.
Iudica has over 25 years of experience in the pharmaceutical industry, including leadership roles in engineering, manufacturing, and supply chain operations. He has served as chief manufacturing officer at Istari Oncology and in multiple manufacturing and operations leadership roles throughout his career including executive roles at Xellia Pharmaceuticals, Pfizer, and Hospira.
Patrick Walsh, chairman and chief executive officer at Alcami Corporation, said, 'Jamie's extensive expertise in drug product manufacturing operations will be integral as we expand the Alcami manufacturing and operations footprint.'
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer